Treatment ResistAnt Depression Subcallosal CingulatE Network DBS

Status: Recruiting
Location: See all (22) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive Disorder (MDD) in adults.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Maximum Age: 70
Healthy Volunteers: f
View:

• The patient must be diagnosed with non-psychotic unipolar Major Depressive Disorder.

• The patient must be in a major depressive episode for ≥12 months or have had at least 3 lifetime depressive episodes.

• The patient has tried and failed a minimum of four different types of antidepressant treatments as measured by a tool designed for this purpose.

• Depression medication and treatment regimen must be stable for a minimum of 4 weeks before the first baseline visit

Locations
United States
Alabama
University of Alabama at Birmingham - Dept. of Psychiatry
RECRUITING
Birmingham
California
UCLA Department of Psychiatry
RECRUITING
Los Angeles
USC University Hospital
RECRUITING
Los Angeles
University of California at Davis
RECRUITING
Sacramento
Florida
USF Health
RECRUITING
Tampa
Georgia
Emory University Hospital
RECRUITING
Atlanta
Illinois
Rush University Medical Center
RECRUITING
Chicago
Massachusetts
Beth Israel Deaconess Medical Center
RECRUITING
Boston
Massachusetts General Hospital
RECRUITING
Boston
Minnesota
University of Minnesota Medical Center Fairview
RECRUITING
Minneapolis
Mayo Clinic
RECRUITING
Rochester
Missouri
Washington University School of Medicine
RECRUITING
St Louis
New Jersey
Robert Wood Johnson University Hospital
RECRUITING
New Brunswick
New York
Mount Sinai Hospital
RECRUITING
New York
Ohio
The Cleveland Clinic Foundation
RECRUITING
Cleveland
Pennsylvania
Pennsylvania Hospital
RECRUITING
Philadelphia
South Carolina
Medical University of South Carolina
RECRUITING
Charleston
Texas
University of Texas Southwestern Medical Center at Dallas
RECRUITING
Dallas
CHI St. Luke's Health Baylor College of Medicine Med. Ctr
RECRUITING
Houston
The Methodist Hospital
RECRUITING
Houston
Utah
University of Utah Hospital
RECRUITING
Salt Lake City
Wisconsin
Medical College of Wisconsin
NOT_YET_RECRUITING
Milwaukee
Contact Information
Primary
Bradley White
bradley.white@abbott.com
+6164432812
Backup
Lyndahl Himes
lyndahl.himes@abbott.com
Time Frame
Start Date: 2024-09-11
Estimated Completion Date: 2029-04
Participants
Target number of participants: 100
Treatments
Sham_comparator: Sham-stimulation group
Group will be implanted with DBS system but device is not activated for the first 12 months. After 12 months, this group can receive stimulation.
Active_comparator: Active-stimulation group
Group will have DBS system activated 2 weeks post-implant.
Related Therapeutic Areas
Sponsors
Leads: Abbott Medical Devices

This content was sourced from clinicaltrials.gov